Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study

The sickle cell gene in India represents a separate occurrence of the HbS mutation (the Asian haplotype), which has occurred against a genetic background characterised by high levels of fetal haemoglobin and widely varying frequencies of alpha thalassaemia. These features, which tend to inhibit sick...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Graham R. Serjeant
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/6b86d2e6106e4c169c426a2a1d638bb2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b86d2e6106e4c169c426a2a1d638bb2
record_format dspace
spelling oai:doaj.org-article:6b86d2e6106e4c169c426a2a1d638bb22021-11-05T13:45:46ZSickle Cell Disease: Thoughts for India From the Jamaican Cohort Study2296-858X10.3389/fmed.2021.745189https://doaj.org/article/6b86d2e6106e4c169c426a2a1d638bb22021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.745189/fullhttps://doaj.org/toc/2296-858XThe sickle cell gene in India represents a separate occurrence of the HbS mutation (the Asian haplotype), which has occurred against a genetic background characterised by high levels of fetal haemoglobin and widely varying frequencies of alpha thalassaemia. These features, which tend to inhibit sickling, change the expression of the disease, which, in India, may be further modified by poor nutrition, malaria and other infections, and limited public health resources. Sickle cell disease in Jamaica is predominantly of African origin (the Benin haplotype) and faces some similar challenges. This review assesses similarities and differences between disease expression in the two countries and seeks to explore lessons from Jamaica, which may be relevant to Indian health care. In particular, it addresses common causes of hospital admission as detailed from Indian clinical experience: anemia, bone pain crisis, and infections.Graham R. SerjeantFrontiers Media S.A.articlesickle cell diseaseJamaicacohort studyIndiageographic comparisonMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic sickle cell disease
Jamaica
cohort study
India
geographic comparison
Medicine (General)
R5-920
spellingShingle sickle cell disease
Jamaica
cohort study
India
geographic comparison
Medicine (General)
R5-920
Graham R. Serjeant
Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
description The sickle cell gene in India represents a separate occurrence of the HbS mutation (the Asian haplotype), which has occurred against a genetic background characterised by high levels of fetal haemoglobin and widely varying frequencies of alpha thalassaemia. These features, which tend to inhibit sickling, change the expression of the disease, which, in India, may be further modified by poor nutrition, malaria and other infections, and limited public health resources. Sickle cell disease in Jamaica is predominantly of African origin (the Benin haplotype) and faces some similar challenges. This review assesses similarities and differences between disease expression in the two countries and seeks to explore lessons from Jamaica, which may be relevant to Indian health care. In particular, it addresses common causes of hospital admission as detailed from Indian clinical experience: anemia, bone pain crisis, and infections.
format article
author Graham R. Serjeant
author_facet Graham R. Serjeant
author_sort Graham R. Serjeant
title Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
title_short Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
title_full Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
title_fullStr Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
title_full_unstemmed Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
title_sort sickle cell disease: thoughts for india from the jamaican cohort study
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/6b86d2e6106e4c169c426a2a1d638bb2
work_keys_str_mv AT grahamrserjeant sicklecelldiseasethoughtsforindiafromthejamaicancohortstudy
_version_ 1718444234034380800